In Brief: SangStat
This article was originally published in The Gray Sheet
Executive Summary
SangStat: Receives 510(k) clearance for Cross-Stat, a monitoring assay that uses the firm's patented soluble human leukocyte antigen (sHLA) technology to help identify matches between donated organs and transplant candidates. The test will be marketed worldwide by Baxter's majority-owned affiliate, Nextran, under 1993 agreement between SangStat and Baxter. Nextran also distributes Pra-Stat, a SangStat-manufactured ELISA test used in matching donated organs with transplant candidates ("The Gray Sheet" Oct. 24, 1994, In Brief)...